The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice

by Abdollahi Amir, Ewerbeck Volker, Gebhard Martha-Maria, Klenke Frank, Huber Peter E, Sckell Axel
Published 2006-01-01

Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis <it>in vivo</it>

by Huber Peter E, Ewerbeck Volker, Gebhard Martha-Maria, Bertl Elisabeth, Abdollahi Amir, Klenke Frank M, Sckell Axel
Published 2007-03-01

Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma

by Bischof Marc, Nikoghosyan Anna, Combs Stephanie E, Karapanagiotou-Schenkel Irini, Unterberg Andreas, Ewerbeck Volker, Haufe Sabine, Rieken Stefan, Schulz-Ertner Daniela, Oertel Susanne, Blattmann Claudia, Jäkel Oliver, Huber Peter, Kulozik Andreas E, Debus Jürgen
Published 2010-03-01